insights_auto
Why is 8QQ down 5.70%?
Dive Deeperchevron_right
8QQ:FRA
AbCellera Biologics Inc
€10.58
arrow_downward
-5.70%(-0.64) 1D
Oct 19, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 8QQ...
Open
€10.44
High
€10.58
Low
€10.44
Mkt. cap
3.86B
Avg. vol.
265.00
Volume
0.00
52-wk high
€12.96
52-wk low
€2.49
No. of employees
562
Open
€10.44
High
€10.58
Low
€10.44
Mkt. cap
3.86B
Avg. vol.
265.00
Volume
0.00
52-wk high
€12.96
52-wk low
€2.49
No. of employees
562
News stories
From web sources and news partners
Action Forex
·
52 minutes ago
The S&P 500 Is on a Dangerous Path
Crypto Briefing
·
5 hours ago
AI stocks now make up 49% of the S&P 500, the second-highest concentration on record
Investing.com
·
5 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
TradingView
·
6 hours ago
There is no fundamental reason for stocks’ reversal, says SA analyst
Profile
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
About AbCellera Biologics Inc
CEOCarl Hansen
Employees562
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorHealth care
Websiteabcellera.com